Day TwoWednesday, 30 April 2025 - GMT (Greenwich Mean Time, GMTZ)

IP Masterclass

Part 1:

• Overview of building IP portfolios in Biotech
  • Current trends and statistics in biotech licensing deals
  • Impact of recent high-profile licensing agreements on the industry
• Importance of Licensing for Biotechs
  • How licensing can provide biotechs with access to new technologies, funding, and markets
  • Strategies for biotechs to position their intellectual property for successful licensing deals
• Key Considerations for Successful Licensing Agreements
  • Essential elements of due diligence in licensing negotiations, valuation methods, and metrics
  • Importance of partnership alignment, ensuring mutual benefit, and managing expectations

Part 2: Licensing fireside chat

Presented by Ingo Lehrke, CBO, Tubulis

• Motivation Behind the Licensing Agreement
  • What drove the decision to pursue the licensing deal? What factors were considered?
• Process Overview
  • Steps taken from initial IP identification and valuation to the signing of the licensing agreement, including challenges encountered and how they were addressed
• Outcome and Lessons Learned
  • Key insights gained from the process and the impact of the licensing deal on the biotech's growth

Part 3:

• Open Floor for Questions
  • How should biotech companies prepare their IP for licensing discussions?
  • What specific attributes do potential licensees look for in a biotech company’s portfolio?
  • How can licensing be used strategically to drive growth and innovation in biotech?
• Wrap-Up Discussion
  • Summarize key takeaways from the workshop
  • Highlight actionable insights for biotech companies considering licensing opportunities